Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Cholangiocarcinoma × Chemotherapy, Adjuvant × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Rectal Neoplasms 5 Lung Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Neoplasms 3 Colonic Neoplasms 3 Central Nervous System Neoplasms 3 Breast Neoplasms, Male 3 Brain Neoplasms 3 Adenocarcinoma Of Esophagus 3 Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Lymphoma 2 Head and Neck Neoplasms 2 Glioblastoma 2 Breast Carcinoma In Situ 2 Vomiting 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Nausea 1 Medulloblastoma 1 Lymphoma, Follicular 1

Interventions

Gemcitabine 25 Cisplatin 17 pembrolizumab 6 Capecitabine 5 Fluorouracil 4 durvalumab 3 Taxes 3 Oxaliplatin 3 Carboplatin 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2 trametinib 2 pemigatinib 2 ivosidenib 2 infigratinib 2 derazantinib 2 atezolizumab 2 Radiotherapy 2 Radiosurgery 2 Platinum 2 Nivolumab 2 Liver Transplantation 2 Leucovorin 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tucatinib 1 trifluridine tipiracil drug combination 1 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡